Khosla Ventures Seed F, Lp investment portfolio

C THE SIGNS LIMITED utilizes an AI-powered platform to assist healthcare professionals in the early detection of cancer by analyzing patient data and recommending diagnostic pathways. Their target market includes healthcare providers, particularly in primary care settings like GP practices, and health systems aiming to improve cancer detection rates and patient outcomes.

Mitra Bio offers a non‑invasive skin‑sampling platform that uses proprietary tape strips to collect biological material for DNA extraction, targeted next‑generation sequencing and comprehensive data analysis, enabling skin‑diagnostics and the development of age‑rejuvenating compounds. The company also conducts biotechnology research extracting DNA from blood, heart and spleen tissues to investigate heart disease.